Eczema, or atopic dermatitis, often worsens during seasonal changes like monsoon and autumn. Fluctuating humidity, allergens, ...

If you or someone you love has eczema, you know treating it can be frustrating. It takes a lot of trial and error to f ...

Shares in French drugmaker Sanofi ($SNY) sickened today as trial data on a new eczema treatment disappointed investors. Met ...

Data from the late-stage trial of amlitelimab weren’t as strong as the results seen in Phase 2, adding to doubts about a drug ...

Sanofi (SNY) stock drops after Phase 3 trial results for amlitelimab, its experimental therapy for eczema, disappointed ...

Daily neglect of brushing, smoking, chewing gutkha or paan masala and other habits can make teeth yellow and foul-smelling.

Eczema can be very distressing for children – and now it seems that its roots may at least partly lie in their mothers ...

Investing.com -- Sanofi (EPA:SASY) shares fell more than 9% on Thursday after the drugmaker reported results from a large trial of its experimental eczema treatment amlitelimab that showed weaker ...

Besides mosquito bites, other causes of itchy bumps on your skin may include hives, other bug bites like flea bites, and ...

The Health Canada approval is based on the results from the DELTA 1 and 2 clinical trials, which included 960 adult patients with moderate to severe CHE (20 per cent of which were Canadian). 2,3 Both ...

Amlitelimab study met its goals but results were not meaningfully better than Dupixent ...

Anyone can have eczema, though CDC data shows that it’s disproportionately diagnosed in women. This complex condition is strongly linked to allergies, asthma, and other autoimmune issues. Common ...